<!-- todo
 colors
  change background
	 white scheme
  black scheme
 -->
<!doctype html>
<head>
 <meta charset="utf-8">
 <title></title>
 <link rel="stylesheet" href="js/jqueryui.css">
 <script src="js/jquery.min.js"></script>
 <script src="js/jqueryui.js"></script>
 <link rel="stylesheet" href="css/style.css">
 <script>
  $(function() {
   $( "div.accordion" ).accordion({
				heightStyle: "content",
				collapsible: true,
				active: false
    });
   });
  </script>
 </head>
<body>
	<div class="accordion">
		<h3>prescriptions</h3><div>
			<div class="accordion">
				<h3>principles</h3><div>
		   syrup must be listed as the last ingredient in compounded prescriptions<br>
		   1 teaspoon is 5g distilled watter or 6.5g syrup<br>
		   1 tablesppon is 15g distilled watter or 20g syrup<br>
		   antibiotics must be given at spaced out intervals<br>
		   100mg of powder = 1ml solvent<br>
		   intramuscular administration in an adult can be a maximum of 5-6ml or a minimum of 2ml<br>
		   saline solution = ampule of 10ml<br>
		   distilled water = ampule of 5ml or 10ml<br>
     </div>
				<h3>compounded - syrup</h3><div>
		   <p>calculate; Tq of syrup, Tq of each ingredient of the syrup</p>
					<p>example; compounded syrup with erythromycin at 50mg/kgbd weight per day for a patient of 15kg. Acetaminophen of 400mg partial dose. Recommended for 4 partial doses per day for 5 days.</p>
					<!--<p>Tq_syrup=tsp*pd*days = 6.5kg * 4 days * 5 days = 130g</p>-->
					<p>prescription</p>
					<p>Header<br>
					Rp/ erythromycin   3.75g<br>
					acetominophen  8g<br>
					syrup          130g<br>
					M.f. potion<br>
					Ds: orally, 1 teaspoon every 6 hours for 5 days. Shake before use.<br>
					Date                      Stamp/Sig<br>
					</p>

     </div>
				<h3>compounded</h3><div>
		   <p>fuck</p>
     </div>
    </div>
   </div>
		<h3>practical exam topics</h3><div>
			<div class=accordion>
				<h3>Pharmacokinetic interactions.	</h3><div>
					<ol>
						<li>interactions on the absorption</li><ul>
							<li>tetracyclines determine inactive complexes with substances containing metal ions (Ca2+, Al3+, Mg2+, Fe2+, Fe3+), which are eliminated from the intestines</li>
						 <li>antacids decrease gastro-intestinal absorption of Digoxin, tetracyclines, quinolones, ketoconazol and itroconazol</li>
						 <li>H2 inhibitors decrease the absorption of ketoconazol</li>
						 <li>erythromycine increases serum level of digoxin (because it destroys bacterias that inactivated oral administrated drugs</li>
						 <li>co-administration of cholestyramine decreases the absorption of: digitalics, diuretics, oral antidiabetics, oral anticoagulants</li>
						 <li>the food from the stomach decreases the absorption of Ampicillin</li>
						 <li>the absorption of ketokonazol is increased in the presence of Coca-cola</li>
						 <li>the absroption of Griseofulrine? is increased in the presenec of fat food</li>
						 </ul>
						<li>interactions on the distribution</li><ul>
						 <li>nonsteroidal antiinflammatory drugs (NSAIDs) bind on the plasma proteins and compete to replace warfarin, determing hemorragy</li>
						 <li>glcocorticosteroids replace saliciclates from plasma proteins and decrease their plasmatic concentration</li>
						 <li>NSAIDs, oral anticoagulants, Ferritoine replace acetylsalicilic acid from plasma proteins and increase its concentration</li>
						 </ul>
						<li>interactiosn on the metabolism</li><ul>
						 <li>these interactions are related to the administration of __ (got cut off)</li>
						 <li>enzymatic inductors decrease the concentration of the associated drugs with the lack of effect: Fenobarbitol, Rifampicin, Spiroconolactone, steroid</li>
						 <li>enzymatic inhibitors increase the concentration of the associated drugs with toxic effects of them: cimetidine, ketoconazole, fenilbutazone, erythromycin, sulphamides, metroconidazol</li>
						 </ul>
						<li>interactiosn on the elimination</li><ul>
						 <li>the uricouric? drug probeuecid increase the elimination of Penicillin G, sulphonamide, indomethacin, due to the competition ofn th erenal tubules mechanisms of elimination</li>
						 <li>Penicillin G and Acetylsalicilic acid complexes on the tubules secretion mechanism</li>
						 <li>the alcolinization of the urine (after acetazolamide administration) increases the leimination of acid substances (Acetylsalicilic acid) and the complexes: chelating agents _ metals</li>
						 <li>the acidication of the urine (after amonium chloride administration) increases the eliination of alcaline substances</li>
						 </ul>
					 </ol>
					</div>
				<h3>Pharmacodynamic interactions. 	</h3><div>
					<ol>
						<li>sinergic interactions</li><ul>
						 <li>increase the pharmacodynamic effects: summation (association Atropine+Scopolamine) and potentiation (Atropine+Paparerine, or Trimetoprim+Sulphamefoxa?)</li>
						 <li>increse the adverse effect<li>
						 <li><li>
						 <li><li>
						 <li><li>
						 <li><li>
				  	</ul>
					 </ol>
					</div>
				<h3>Adverse effects of drugs. Pharmacovigilance report.</h3><div>
					</div>
				<h3>General principles in the treatment of intoxications.</h3><div>
					</div>
				<h3>Parasympathetic substances blockers - pharmacodynamic effects. </h3><div>
					</div>
				<h3>Acute and chronic intoxication with organophosphate. </h3><div>
					</div>
				<h3>Acute and chronic intoxication with nicotine. </h3><div>
					</div>
				<h3>Acute intoxication with atropine.</h3><div>
					</div>
				<h3>Substances releasing cathecolamines. </h3><div>
					</div>
				<h3>Acute and chronic intoxication with cocaine.</h3><div>
					</div>
				<h3>Cardiovascular and metabolic effects of betablockers. </h3><div>
					</div>
				<h3>Intoxication with carbon monoxide. </h3><div>
					</div>
				<h3>Drugs acting on vascular smooth muscle.</h3><div>
					</div>
				<h3>Intoxication avec methylxantines.</h3><div>
					</div>
				<h3>Intoxication with cianures. </h3><div>
					</div>
				<h3>Acute intoxication with methemoglobinizant substances.	</h3><div>
					</div>
				<h3>Drugs acting on bronchial smooth muscle. </h3><div>
					</div>
				<h3>Acute intoxication with organic solvents. </h3><div>
					</div>
				<h3>Drugs active on lipid metabolism disorders.</h3><div>
					</div>
				<h3>Drugs indicated for the treatment of angina pectoris. </h3><div>
					</div>
				<h3>Intoxication avec digitalics. </h3><div>
					</div>
				<h3>Overdosage during heparin treatment. </h3><div>
					</div>
				<h3>Overdosage during oral anticoagulants treatment.</h3><div>
					</div>
				<h3>Intoxication with heavy metals.	</h3><div>
					</div>
				<h3>Drugs indicated in the treatment of hypertension, hypotension, heart failure. </h3><div>
					</div>
				<h3>Choice of antibacterial drug depending on capacity of passing the physiological barriers, on different associated diseases. </h3><div>
					</div>
				<h3>Acute intoxication with acids and alcah3.	</h3><div>
					</div>
				<h3>Choice of antibacterial drug depending on antibacterial spectrum (H. pylori, K. pneumoniae, S. aureus, P. aeruginosa).</h3><div>
					</div>
				<h3>Interactions of imidazole derivatives (antifungal, antiprotozoal).</h3><div>
					</div>
				<h3>Drugs indicated in glaucoma. </h3><div>
					</div>
				<h3>Interactions of antiacids. </h3><div>
					</div>
				<h3>Drugs inhibiting digestive smooth muscle.</h3><div>
					</div>
    </div>
   </div>
		<h3>1 - pharmacodynamics</h3><div>
			<p><b>Pharmacology</b> is study of substances that interact with living systems through chemical processes, especially by binding to regulatory molecules and activating or inhibiting normal body processes. Effects can be therapeutic (medical pharmacology) or toxic (toxicology). A drug is a substance that brings about change in the body and can be synthesized by the body or foreign. <b>Toxins</b> are poisons of biological origins. <b>Pharmacodynamics</b> action of drugs on the body. <b>Pharmacokinetics</b> are actions of the body on the drug - <b>ADME</b> (absorption, distribution, metaoblism, excretion).</p>
   <ul>
    <li><b>principal</b> - the use of the drug (it have some intensity) or secondary (beneficial or adverse) - small intensity </li>
    <li><b>local</b> (topical): skin, mucosa, gut or general (systemic) </li>
    <li><b>reversibile</b> - that last till the inactivation/elimination of the substance or irreversible</li>
    <li>can be receptor mediated or non-receptor mediated</li>
    </ul>
   </div>
		<h3>2 - pharmacokinetics</h3><div>
		 <p>hello</p>
   </div>
  <h3>3 - parasympathomimetics</h3><div>
	  <p>A receptor is cholinergic if it uses <b>Acetylcholine</b>, which is a biogenic amine synthetized in the body from <b>choline</b> and <b>acetylcoenzime</b>. A under the action <b>colinacetil-transferase</b>. Ach released from presynaptic endings can bind to cholinergic receptors (activating them) or <b>acetylcholinersterase</b> (inactivating Ach). The cholinesterase system includes; Acetylcholinesterase is present in cholingergic neruons, cholinergic synapses and other tissues and <b>pseudocholinesterase</b> in the plasma, liver, intestines, skin, glial cells and other tissues. The result is choline (can be reused in Ach syntehsis) and acetic acid (in krebs cycle). Within 2-3msec the released Ach interacts with the receptor on the postsynaptic membrane causing stimulation of the nerve.<b>Parasympathomimetics</b> (cholinergics, cholinergic agonists) produce similar effects of parasympathetic stimulation and activation of muscarinic and nicotinic neuroeffector cholinergic synapses.</p>
   <b>direct</b><ul>
    <li>a) coline esters: naturals: <b>acetylcholine</b>, synthetics: <b>Carbachol</b>, <b>Betanechol</b>, <b>Metacholine</b></li>
    <li>b) alkaloids: <b>Pilocarpine</b></li>
    </ul>
   <b>indirect (anticholinesterases)</b><ul>
    <li>a) Reversible: <b>Physostigmine</b>, <b>Edrophonium</b>, <b>Neostigmine</b>, <b>Piridostigmine</b>, <b>Ambenonium ChlorideChloride</b></li>
    <li>b) Irreversible: <b>Ecothiopate</b>, <b>Metrifonate</b>, <b>Fluostigmine</b>, <b>Paraoxon</b>, <b>Sarin </b></li>
    </ul>
			<img src="img/3-1.png"><br>
			<img src="img/3-2.png"><br>
			<p><b>Nicotinic receptors</b> are present on the ganglia, while <b>muscarinic</b> receptors are present on the target tissue. Muscarinic receptors are specifically activated by muscarine (Amanita muscaria), and there are 5 subtypes: neuroeffector <b>parasympathetic synapses</b> in smooth muscle, heart, and exocrine glands. Neuroeffector <b>sympathetic</b> synapses in sweat glands and brain.	Nicotinic receptors are specifically activated by nicotine (Tobacco). 2 subtypes. Nm (N1) in neuromuscular junction. Nn (N2) in autonomic interneuronal and adrenal medula (medulosuprarenal gland).</p>
			<img src="img/3-3.png"><br>
   <ul>Direct Parasympathomimetics
				<li><b>choline esters</b> prototype is acetylcholine, induces muscarinic and nicotinic receptors. Cholinergic receptors increase the permeability of cells membrane for some ions. On excitoconductor heart tissue, increase the permeability for K+ and Cl- -ions, resulting in hyperpolarization of membrane and thus decrease of heart rate (M). On autonomic ganglia, smooth muscles (M) and skeletal muscles (N)  increases the permeability for Na+, resulting in depolarization of membrane and increasing the muscle tone. </li>
				<li>On exocrine  glands  (sweat, salivary (M)) - increases the permeability for Ca+- stimulates the gland secretion Muscarinic effects; cholinergic receptors from the postynaptic membrane of the effector cells (in small doses). These effects are antagonized by Atropine.</li>
				<li>a) Cardiovascular system: depressant effect on the heart ( - inotrope - chronotrope - dromotrope) and vessels ( vasodilation resulting in decreased bp due to NO release from endothelial cells).</li>
				<li>b) respiratory system; bronchoconstriction, bronchial gland hypersecretion, chrysis of dyspnea expiratory (in asthmatics) </li>
				<li>c) digestive sysytem: stimulation of g-i smooth muscle, increase of digestive glands secretion (gastric acid hypersecretion), sphincters relaxation, stimulation of bile and gall bladder<li>
				<li>d) renal excretory system; bladder contractions, sphincter relaxation</li>
				<li>e) eye; active miosis (contraction of circular smooth muscle of the iris),decrease intraocular pressure (local instilation)4</li>
 			</ul>
			<img src="img/3-2.png"><br>
			</div>
  <h3>4 - parasympatholytics</h3><div>
			 <p>hello</p>
    </div>
  <h3>5 - sympathomimetics</h3><div>
			 <p>hello</p>
    </div>
  <h3>6 - sympatholytics</h3><div>
			 <p>hello</p>
    </div>
  <h3>7 - smooth muscle drugs</h3><div>
			 <p>hello</p>
    </div>
  <h3>8 - autacoids</h3><div>
			 <p>hello</p>
    </div>
  <h3>9 - cardiotonics</h3><div>
			 <p>hello</p>
    </div>
  <h3>10 - diuretics</h3><div>
			 <p>hello</p>
    </div>
  <h3>11 - antibiotics </h3><div>
			 <p>hello</p>
    </div>
  <h3>12 - gastrointestinal drugs</h3><div>
			 <p>hello</p>
    </div>
  </div>
 </body>
